Published Phase 1 data in Sexual Medicine strengthen the scientific foundation for Daré Bioscience’s proprietary topical Sildenafil Cream, 3.6%At ...
Daré Bioscience, Inc. ( DARE) announced the peer-reviewed publication of Phase 1 clinical data evaluating its proprietary Sildenafil Cream, 3.6% in healthy adult men, with results showing ...
Sildenafil, which is also called sildenafil citrate, comes as an oral tablet. The drug also comes as an oral liquid suspension and IV infusion. However, this article does not cover these forms. It ...
Sildenafil is a generic prescription drug that’s used to treat erectile dysfunction (ED) and pulmonary arterial hypertension (PAH). Sildenafil is available as the brand-name drugs Revatio and Viagra.
Verywell Health on MSN
7 medications that may interact with green tea
Medically reviewed by Violetta Shamilova, PharmD Key Takeaways Green tea can change how some drugs are absorbed or processed, ...
Viagra is so popular that its name has become synonymous with ED treatment — just like Ziploc has with plastic bags. But the active ingredient in Viagra is sildenafil. Pfizer Pharmaceuticals patented ...
Hosted on MSN
Is sildenafil safe for this common male problem?
This story was reviewed by Mike Bohl, MD. In the ‘80s, researchers set out to test a medication called sildenafil citrate for treating high blood pressure and angina (chest pain) from heart disease.
The aim of our single-dose, home-use study was to investigate whether sildenafil improves erectile function in young healthy males. In all, 92 young healthy men volunteers (age 20–40 y) were evaluated ...
We randomly assigned, in a 1:1 ratio, patients with IPF and a Dl CO of 35% or less of the predicted value to receive nintedanib at a dose of 150 mg twice daily plus sildenafil at a dose of 20 mg three ...
Oh honey. Did someone put some tadalafil or sildenafil in the honey-based product that you are taking without telling you? (Photo: Getty) If you found yourself getting, ahem, a little too excited ...
The use of sildenafil does not appear to reduce the risk for fetal hypoxia in women, according to results from a phase 3 randomized clinical trial published in JAMA. Researchers have studied using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results